Chengdu Easton Biopharmaceuticals Co Ltd (688513) — Capital Reinvestment Ratio
Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥61.35 Million) in capital expenditures (CN¥24.30 Million). Check how tangible is Chengdu Easton Biopharmaceuticals Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chengdu Easton Biopharmaceuticals Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Chengdu Easton Biopharmaceuticals Co Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see Chengdu Easton Biopharmaceuticals Co Ltd (688513) cash flow conversion.
Annual Capital Reinvestment Ratio for Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. See Chengdu Easton Biopharmaceuticals Co Ltd (688513) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥264.94 Million | CN¥86.28 Million | ▼ -27.0% |
| 2024 | 0.45x | CN¥263.24 Million | CN¥117.42 Million | ▼ -29.9% |
| 2023 | 0.64x | CN¥275.25 Million | CN¥175.26 Million | ▼ -71.5% |
| 2022 | 2.23x | CN¥151.94 Million | CN¥339.33 Million | ▲ +28.6% |
| 2021 | 1.74x | CN¥147.60 Million | CN¥256.29 Million | ▲ +36.7% |
| 2020 | 1.27x | CN¥156.52 Million | CN¥198.81 Million | ▲ +88.8% |
| 2019 | 0.67x | CN¥141.83 Million | CN¥95.41 Million | ▲ +46.4% |
| 2018 | 0.46x | CN¥166.79 Million | CN¥76.63 Million | ▲ +71.0% |
| 2017 | 0.27x | CN¥85.70 Million | CN¥23.02 Million | ▲ +59.8% |
| 2016 | 0.17x | CN¥106.06 Million | CN¥17.83 Million | ▼ -76.0% |
| 2015 | 0.70x | CN¥50.57 Million | CN¥35.43 Million | ▲ +48.5% |
| 2014 | 0.47x | CN¥46.71 Million | CN¥22.04 Million | ▼ -82.6% |
| 2013 | 2.71x | CN¥28.12 Million | CN¥76.11 Million | — |